Transcription factor AP2 enhances malignancy of non-small cell lung cancer through upregulation of USP22 gene expression
Abstract Background Ubiquitin-specific protease 22 (USP22), a putative cancer stem cell marker, is frequently upregulated in cancers, and USP22 overexpression is associated with aggressive growth, metastasis, and therapy resistance in various human cancers including lung cancer. However, USP22 gene...
Main Authors: | Ting Sun, Keqiang Zhang, Wendong Li, Yunze Liu, Rajendra P. Pangeni, Aimin Li, Leonidas Arvanitis, Dan J. Raz |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-09-01
|
Series: | Cell Communication and Signaling |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12964-022-00946-9 |
Similar Items
-
Inhibition of USP7 upregulates USP22 and activates its downstream cancer-related signaling pathways in human cancer cells
by: Keqiang Zhang, et al.
Published: (2023-11-01) -
Ubiquitin-specific protease 22 is critical to in vivo angiogenesis, growth and metastasis of non-small cell lung cancer
by: Keqiang Zhang, et al.
Published: (2019-12-01) -
Over-Expression of Deubiquitinating Enzyme USP14 in Lung Adenocarcinoma Promotes Proliferation through the Accumulation of β-Catenin
by: Ning Wu, et al.
Published: (2013-05-01) -
Varions Mechanisms of Deubiquitinating Enzyme USP22 in Cancer
by: SUN Yue, et al.
Published: (2020-12-01) -
Upregulation of USP22 and ABCC1 during Sorafenib Treatment of Hepatocellular Carcinoma Contribute to Development of Resistance
by: Yung-Sheng Chang, et al.
Published: (2022-02-01)